Mqs Management LLC Charles River Laboratories International, Inc. Transaction History

Mqs Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$206.39 - $268.73 $322,174 - $419,487	1,561 New	1,561 $322,000
Q2 2023 Aug 10, 2023	BUY	$183.71 - $210.25 $347,579 - $397,793	1,892 New	1,892 $397,000
Q2 2022 Aug 05, 2022	BUY	$204.13 - $302.4 $386,418 - $572,443	1,893 Added 212.7%	2,783 $595,000
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $84,062 - $119,134	-329 Reduced 26.99%	890 $253,000
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $428,332 - $546,940	1,219 New	1,219 $459,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mqs Management LLC with notifications on news.